Cellular and Molecular Neurobiology

, Volume 33, Issue 8, pp 1065–1074 | Cite as

Neuroprotective Potential of Bacopa monnieri and Bacoside A Against Dopamine Receptor Dysfunction in the Cerebral Cortex of Neonatal Hypoglycaemic Rats

  • Roshni Baby Thomas
  • Shilpa Joy
  • M. S. Ajayan
  • C. S. PauloseEmail author
Original Research


Neonatal hypoglycaemia initiates a series of events leading to neuronal death, even if glucose and glycogen stores return to normal. Disturbances in the cortical dopaminergic function affect memory and cognition. We recommend Bacopa monnieri extract or Bacoside A to treat neonatal hypoglycaemia. We investigated the alterations in dopaminergic functions by studying the Dopamine D1 and D2 receptor subtypes. Receptor-binding studies revealed a significant decrease (p < 0.001) in dopamine D1 receptor number in the hypoglycaemic condition, suggesting cognitive dysfunction. cAMP content was significantly (p < 0.001) downregulated in hypoglycaemic neonatal rats indicating the reduction in cell signalling of the dopamine D1 receptors. It is attributed to the deficits in spatial learning and memory. Hypoglycaemic neonatal rats treated with Bacopa extract alone and Bacoside A ameliorated the dopaminergic and cAMP imbalance as effectively as the glucose therapy. The upregulated Bax expression in the present study indicates the high cell death in hypoglycaemic neonatal rats. Enzyme assay of SOD confirmed cortical cell death due to free radical accumulation. The gene expression of SOD in the cortex was significantly downregulated (p < 0.001). Bacopa treatment showed a significant reversal in the altered gene expression parameters (p < 0.001) of Bax and SOD. Our results suggest that in the rat experimental model of neonatal hypoglycaemia, Bacopa extract improved alterations in D1, D2 receptor expression, cAMP signalling and cell death resulting from oxidative stress. This is an important area of study given the significant motor and cognitive impairment that may arise from neonatal hypoglycaemia if proper treatment is not implemented.


Neonatal hypoglycaemia Dopamine Bacopa monnieri Bacoside A Cerebral cortex 



This work was supported by research Grants from the DBT, DST, ICMR, Govt. of India, and the KSCSTE, Govt. of Kerala, to Dr. C. S. Paulose.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Aral YZ, Gucuyener K, Atalay Y, Hasanoglu A, Turkyilmaz C, Sayal A, Biberoglu G (1998) Role of excitatory aminoacids in neonatal hypoglycemia. Acta Paediatr Jpn 40:303–306PubMedCrossRefGoogle Scholar
  2. Auer RN (1991) Excitotoxic mechanisms, and age-related susceptibility to brain damage in ischemia, hypoglycemia and toxic mussel poisoning. Neurotoxicology 12:541–546PubMedGoogle Scholar
  3. Auer RN, Siesjo BK (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24:699–707PubMedCrossRefGoogle Scholar
  4. Auer RN, Siesjo BK (1993) Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab 7:611–625PubMedCrossRefGoogle Scholar
  5. Azdad K, Gall D, Woods AS, Ledent C, Ferre S, Schiffmann SN (2009) Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization. Neuropsychopharmacology 34(4):972–986PubMedCrossRefGoogle Scholar
  6. Blanca ÁF, Irene CP (2011) Neonatal hypoglycemia: current concepts. In: Rigobelo E (ed) Hypoglycemia: causes and occurrences. InTech, Rijeka. ISBN: 978-953-307-657-7Google Scholar
  7. Blattner RJ (1968) Central nervous system damage and hypoglycemia. Pediatrics 72:904–906CrossRefGoogle Scholar
  8. Burns CM, Rutherford MA, Boardman JP, Cowan FM (2008) Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 122:65–74PubMedCrossRefGoogle Scholar
  9. Butcher SP, Sandberg M, Hagberg H, Hamberger A (1987) Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia. J Neurochem 48:722–728PubMedCrossRefGoogle Scholar
  10. Calabresi P, Centonze D, Pisani A, Bernardi G (1997) A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum. J Cereb Blood Flow Metab 17:1121–1126PubMedCrossRefGoogle Scholar
  11. Cornblath M, Schwartz R (1976) Disorders of carbohydrate metabolism in infancy. WB Saunders, Philadelphia, pp 155–217Google Scholar
  12. Creese I, Hess ES (1986) Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia. Clin Neuropharmacol 9(suppl. 4):14–16PubMedGoogle Scholar
  13. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31–55PubMedCrossRefGoogle Scholar
  14. Fowler JC (1993) Glucose deprivation results in a lactate preventable increase in adenosine and depression of synaptic transmission in rat hippocampal slices. J Neurochem 60:572–576PubMedCrossRefGoogle Scholar
  15. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. J Neurochem 13:655–659PubMedCrossRefGoogle Scholar
  16. Gohil KJ, Patel JA (2010) A review on Bacopa monniera: current research and future prospects. Int J Green Pharm 4:1–9CrossRefGoogle Scholar
  17. Goldberg TE, Bigelow LB, Weinberger DR, Daniel DG, Kleinman JE (1991) Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatry 148(1):78–84PubMedGoogle Scholar
  18. Gurden H, Takita M, Jay TM (2000) Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal prefrontal cortex synapses in vivo. J Neurosci 20:RC106Google Scholar
  19. Handa SS (1998) Indian herbal pharmacopoeia, vol 1. IDMA, Mumbai, pp 30–37Google Scholar
  20. Hawdon JM (1999) Hypoglycaemia and the neonatal brain. Eur J Pediatr 158(Supp 1):S9–S12PubMedCrossRefGoogle Scholar
  21. Hernandez-Lopez S, Tkatch T, Perez-Garci E, Galarraga E, Bargas J, Hamm H, Surmeier DJ (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC [beta] 1-IP3-calcineurin-signaling cascade. J Neurosci 20(24):8987–8995PubMedGoogle Scholar
  22. Hervé D, Rogard M, Lévi-Strauss M (1995) Molecular analysis of the multiple Golf subunit mRNAs in the rat brain. Mol Brain Res 32:125–134PubMedCrossRefGoogle Scholar
  23. Janssen PAJ, Niemegeers CJE, Awouters F, Schellwkens KHL et al (1988) Pharmacology of risperidone (R-64- 766). A new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 344:685–693Google Scholar
  24. Jobin M, Jes P, Nandhu MS, Paulose CS (2010) Bacopa monnieri and Bacoside-A for ameliorating epilepsy associated behavioral deficits. Fitoterapia 8(1):5315–5322Google Scholar
  25. Jones RAK, Roberton NRC (1984) Problems of the small-for-dates baby. Clin Obstet Gynecol 11:499–524Google Scholar
  26. Junqing W, Junhui W, Zhaoming Z (2005) Oxidative stress in mouse brain exposed to lead. Ann Occup Hyg 50(4):405–409Google Scholar
  27. Kalhan SC, Oliven A, King KC, Lucero C (1986) Role of glucose in the regulation of endogenous glucose production in the human newborn. Pediatr Res 20:49–51PubMedCrossRefGoogle Scholar
  28. Karp MM (1989) Hypoglycemia in diabetes among children and adolescents. Indian J Pediatr 56(Suppl 1):S93–S98PubMedCrossRefGoogle Scholar
  29. Kiritikar KR, Basu BD (1994) Indian medicinal plants, vol I. Bishen Singh Mahendrapal Singh, Dehradun, pp 1816–1817Google Scholar
  30. Lidow MS, Goldman-Rakic PS (1994) A common action of clozapine, haloperidol and remoxipride on D1- and D2-dopamine receptors in the primate cerebral cortex. Proc Natl Acad Sci USA 91:4353–4356PubMedCrossRefGoogle Scholar
  31. Lidow MS, Elsworth JD, Patricia S, Rakic G (1997) Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J Pharmacol Exp Ther 281:597–603PubMedGoogle Scholar
  32. Lowry OH, Rosenbrough NH, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  33. McConnell SK (1991) The generation of neuronal diversity in the central nervous system. Annu Rev Neurosci 14:269–300PubMedCrossRefGoogle Scholar
  34. McGowan JE, Zanelli SA, Haynes-Laing AG, Mishra OP, Delivoria-Papadopoulos M (2002) Modification of glutamate binding sites in newborn brain during hypoglycemia. Brain Res 92:780–786Google Scholar
  35. Mina K, Zhao-Xue Y, Bertil BF, Scott AR (2005) Susceptibility of the developing brain to acute hypoglycaemia involving A1 adenosine receptor activation. Am J Physiol Endocrinol Metab 289:E562–E569CrossRefGoogle Scholar
  36. Missale C, Nash SR, Robinson SW et al (1998) Dopamine receptors: from structure to function. Physiol Rev 78(1):189–225PubMedGoogle Scholar
  37. Mitanchez D (2008) Ontogenesis of glucose regulation in neonate and consequences in neonatal management. Arch Pediatr 15:164–174Google Scholar
  38. Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Chui DH, Tabira T (2000) Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J Neurosci 20:1568–1574PubMedGoogle Scholar
  39. Moley KH, Mueckler MM (2000) Glucose transport and apoptosis. Apoptosis 5:99–105PubMedCrossRefGoogle Scholar
  40. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R et al (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18:4446–4454PubMedCrossRefGoogle Scholar
  41. Otani S, Blond O, Desce JM, Crepel F (1998) Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience 85:669–676PubMedCrossRefGoogle Scholar
  42. Pal R, Sarin JPS (1992) Quantitative determination of bacosides by UV-spectrophotometry. Indian J Pharm Sci 54:17–18Google Scholar
  43. Ryan C, Vega A, Drash A (1985) Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75:921–927PubMedGoogle Scholar
  44. Sairam K, Rao CV, Babu MD, Goel RK (2001) Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine 84:23–30Google Scholar
  45. Sann L, Morel Y, Lasne Y (1983) Effects of hydrocortisone on intravenous glucose tolerance in small-for-gestational-age infants. Helv Paediatr Acta 38:475–482PubMedGoogle Scholar
  46. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672CrossRefGoogle Scholar
  47. Schneider JS, Roeltgen DP (1993) Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys. Brain Res 615(2):351–354PubMedCrossRefGoogle Scholar
  48. Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C (1989) Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci USA 86:10156–10160PubMedCrossRefGoogle Scholar
  49. So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O’Dowd BF, George SR (2009) Calcium signaling by dopamine D5 receptor and D5–D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1–D2 receptor heterooligomers. Mol Pharmacol 75(4):843–854PubMedCrossRefGoogle Scholar
  50. Strange PG (1991) D1/D2 dopamine receptor interaction at the biochemical level. Trends Pharmacol Sci 12:48–49PubMedCrossRefGoogle Scholar
  51. Sumathi T, Nathiya VC, Sakthikumar M (2011) Protective effect of bacoside-A against morphine-induced oxidative stress in rats. Indian J Pharm Sci 73(4):409–415PubMedGoogle Scholar
  52. Turner CP, Pulciani D, Rivkees SA (2002a) Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 17:821–832Google Scholar
  53. Turner CP, Yan H, Schwartz M, Othman T, Rivkees SA (2002b) A1 adenosine receptor activation induces ventriculomegaly and white matter loss. Neuroreport 13:1199–1204PubMedCrossRefGoogle Scholar
  54. Vannucci RC, Vannucci SJ (1978) Cerebral carbohydrate metabolism during hypoglycemia and anoxia in newborn rats. Ann Neurol 4:73–79PubMedCrossRefGoogle Scholar
  55. Vannucci RC, Vannucci SJ (2001) Hypoglycemic brain injury. Semin Neonatol 6:147–155PubMedCrossRefGoogle Scholar
  56. Ward PM, Desphande S (2005) Metabolic adaptation at birth. Semin Fetal Neonatal Med 10(4):341–350CrossRefGoogle Scholar
  57. Wieloch T (1985) Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist. Science 230:681–683PubMedCrossRefGoogle Scholar
  58. Wight NE (2006) Hypoglycemia in breastfed neonates. Breastfeed Med 14:253–262CrossRefGoogle Scholar
  59. Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572–575PubMedCrossRefGoogle Scholar
  60. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528–8535PubMedGoogle Scholar
  61. Zanellia SA, Spandou E, Mishra OP, Delivoria-Papadopoulos M (2005) Hypoxia modifies nuclear calcium uptake pathways in the cerebral cortex of the guinea-pig fetus. Neuroscience 130(4):949–955CrossRefGoogle Scholar
  62. Zhu PJ, Krnjevic K (1993) Adenosine release is a major cause of failure of synaptic transmission during hypoglycaemia in rat hippocampal slices. Neurosci Lett 155:128–131PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Roshni Baby Thomas
    • 1
  • Shilpa Joy
    • 1
  • M. S. Ajayan
    • 1
  • C. S. Paulose
    • 1
    Email author
  1. 1.Molecular Neurobiology and Cell Biology Unit, Centre for Neuroscience, Department of BiotechnologyCochin University of Science and TechnologyCochinIndia

Personalised recommendations